Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Mrc mutation
(0 available);
any
Fgf8 mutation
(18 available)
Fgf8tm2Moon mutation
(0 available);
any
Fgf8 mutation
(18 available)
Isl1tm1(cre)Sev mutation
(1 available);
any
Isl1 mutation
(33 available)
|
|
|
mortality/aging
|
• severely affected mutants (35%) die by E10; most (65%) survive to birth
|
embryo
|
• at E8.75 -10.5, surviving mutants have small pharyngeal arches
|
cellular
|
• excess apoptotic cells are detected at the 7-9 somite stage in ventral endoderm and adjacent smooth muscle
|
cardiovascular system
|
• conotruncal cushions are hypocellular compared to controls; fusion of cushions to form AP septum is delayed in mutants
|
|
• 100% of E18.5/newborns have PTA
|
|
• at E8.75 -10.5, surviving mutants have severe right ventricle hypoplasia
|
craniofacial
|
• at E8.75 -10.5, surviving mutants have small pharyngeal arches
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Mrc mutation
(0 available);
any
Fgf8 mutation
(18 available)
Fgf8tm2Moon mutation
(0 available);
any
Fgf8 mutation
(18 available)
Isl1tm1(cre)Sev mutation
(1 available);
any
Isl1 mutation
(33 available)
|
|
|
cardiovascular system
|
• in explants no cells manage to successfully undergo endothelial to mesenchymal transformation
|
|
• outflow tracts are short and abnormally angulated
|
|
• outflow tract cushions contain less cardiac jelly and fewer mesenchymal cells
• proximal outflow tract cushions are thinner and contain fewer cells while distal cushions are thinner but do not display a change in cell density
|
|
• all show type III PTA (the outflow tract is unseptated along its entire proximodstal extent)
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Mrc mutation
(0 available);
any
Fgf8 mutation
(18 available)
Fgf8tm2Moon mutation
(0 available);
any
Fgf8 mutation
(18 available)
Mesp1tm2(cre)Ysa mutation
(1 available);
any
Mesp1 mutation
(17 available)
|
|
|
mortality/aging
|
• severely affected Fgf8-deficient embryos (65%) die by E10
|
homeostasis/metabolism
cardiovascular system
|
• OFTs are short or absent in 65% of embryos
|
|
• heart tube is hypoplastic in 65% of embryos
|
|
• 30% of the embryos born show transposition of the great arteries
|
|
• there is a single dilated atrium in 65% of embryos
|
|
• there is a single dilated ventricle in 65% of embryos
|
|
• 40% of newborns also have a bicuspid aortic valve
|
|
• 40% of newborns also have a bicuspid pulmonary valve
|
|
• 35% of embryos survive but have small right ventricles at midgestation
|
|
• embryos die by E10 with pericardial effusion in 65% of embryos
|
cellular
|
• excess apoptotic cells are detected at the 7-9 somite stage in ventral endoderm and adjacent smooth muscle
|
|
• at the 4 somite stage, mutants have 46% fewer proliferating cells in crescent mesoderm; this persisted to the 9 somite stage
• proliferating cells are decreased in the proximal outflow tract and pharyngeal epithelium at the 9 somite stage
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Mrc mutation
(0 available);
any
Fgf8 mutation
(18 available)
Fgf8tm2Moon mutation
(0 available);
any
Fgf8 mutation
(18 available)
Foxa2tm2.1(cre/Esr1*)Moon mutation
(1 available);
any
Foxa2 mutation
(26 available)
|
|
|
cardiovascular system
N |
• no defects in outflow tract development are seen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Mrc mutation
(0 available);
any
Fgf8 mutation
(18 available)
Fgf8tm2Moon mutation
(0 available);
any
Fgf8 mutation
(18 available)
Tg(Mef2c-cre)2Blk mutation
(1 available)
|
|
|
cardiovascular system
|
• 25% of mutants have TGA and double outlet right ventricle
|
|
• 25% of mutants have TGA and double outlet right ventricle
|